N/A
Completed N=4,658
International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)
Source: ClinicalTrials.gov NCT01119716 ↗Enrolled (actual)
4,658
Serious AEs
—
Results posted
Jan 2014
Primary outcomePrimary: Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission) — 1.3; 1.6; 1.4; 2.3 Percentage of Participants
Summary
This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission) |
1.3; 1.6; 1.4; 2.3; 3.5; 2.8 | — |
| PRIMARY Co-Morbidity in Participants Presenting With Atrial Fibrillation at Baseline (Admission) |
7.8; 7.1; 7.5; 6.3; 5.1; 5.8 | — |
| PRIMARY Clinical Type of Atrial Fibrillation at Baseline (Admission) |
29.2; 33.6; 30.8; 27.2; 31.9; 28.9 | — |
| PRIMARY Treatments Utilized for Participants for Atrial Fibrillation |
1677; 792; 2469; 705; 609; 1314 | — |
| PRIMARY Percentage of Participants Who Had a Successful Electrical or Pharmacological Cardioversion |
69.5; 55.1; 64.2; 30.5; 44.9; 35.8 | — |
| PRIMARY Complications Experienced by Participants Who Underwent a Cardioversion for Treatment of Atrial Fibrillation |
2; 2; 4; 7; 3; 10 | — |
Eligibility Criteria
Inclusion Criteria
- Participant with documented atrial fibrillation (confirmed by electrocardiogram) in the hospital setting at the time of enrollment
- Planned cardioversion (of atrial fibrillation)
Exclusion Criteria
- Already enrolled in this or any other clinical trial
- Atrial flutter
Data sourced from ClinicalTrials.gov (NCT01119716). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.